Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
Scott McComb(University of Ottawa), Risini D. Weeratna(National Research Council Canada), Natasha Kekre(Ottawa Hospital), Christine Gadoury(National Research Council Canada), Brian A. Keller(University of Ottawa), Harold Atkins(University of Ottawa), John K. Webb(UNSW Sydney), Annie Aubry(National Research Council Canada), Shannon Ryan(National Research Council Canada), Eric Yung(Canada's Michael Smith Genome Sciences Centre), Rénald Gilbert(National Research Council Canada), Jez Huang(National Research Council Canada), Sharlene Faulkes(University of Ottawa), Brad H. Nelson(University of British Columbia), Anna Jezierski(Natural Sciences and Engineering Research Council of Canada), Shalini Raphael(National Research Council Canada), Devanand M. Pinto(National Research Council Canada), Robert A. Holt(University of British Columbia), Anne Marcil(National Research Council Canada), Henk van Faassen(National Research Council Canada), Alex Shepherd(University of Ottawa), Kevin A. Hay(Occupational Cancer Research Centre), Mehdi Arbabi‐Ghahroudi(University of Ottawa), Ahmed Zafer(National Research Council Canada), Komal Gurnani(National Research Council Canada), Greg Hussack(National Research Council Canada), Robert A. Pon(National Research Council Canada), Umar Iqbal(National Research Council Canada), Julie S. Nielsen, Mhairi K. Sigrist(Terry Fox Research Institute), Susanne MacLean(National Research Council Canada), Qin Zhu, Anindita Chattopadhyay(National Research Council Canada), Tina Nguyen(National Research Council Canada), Dorothy Fatehi(National Research Council Canada), Cunle Wu(National Research Council Canada), Michael Rutherford(University of Ottawa)
Cited by 12
Related Papers
The Sequence of the Human Genome
|Science|2001|13.7k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Integrated genomic and molecular characterization of cervical cancer
|Nature|2017|1.6k